Highlights and Quick Summary
- Income after Tax for the quarter ending September 30, 2023 was $-22 Million (a -47.22% decrease compared to previous quarter)
- Year-over-year quarterly Income after Tax increased by 12.96%
- Annual Income after Tax for 2022 was $-105 Million (a 3.91% increase from previous year)
- Annual Income after Tax for 2021 was $-101 Million (a 603.41% increase from previous year)
- Annual Income after Tax for 2020 was $-14.4 Million (a 118.0% increase from previous year)
- Twelve month Income after Tax ending September 30, 2023 was $-106 Million (a -4.71% decrease compared to previous quarter)
- Twelve month trailing Income after Tax increased by 1.51% year-over-year
Trailing Income after Tax for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-106 Million | $-112 Million | $-98.8 Million | $-105 Million |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income after Tax of Absci Corporation
Most recent Income after Taxof ABSI including historical data for past 10 years.Interactive Chart of Income after Tax of Absci Corporation
Absci Corporation Income after Tax for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-21.99 | $-41.67 | $-23.36 | – | – |
| 2022 | $-19.47 | $-27.26 | $-28.68 | $-29.49 | $-104.9 |
| 2021 | $-25.17 | $-23.63 | $-41.2 | $-10.96 | $-100.96 |
| 2020 | $-4.94 | $-3.75 | $-3.01 | $-2.66 | $-14.35 |
| 2019 | – | – | – | – | $-6.58 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology